Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
PDS Biotechnology
PDSB
$12.9M
| $600K | ﹤0.01% |
+120,700
| New | +$600K |
|
2702
Shake Shack
SHAK
$3.02B
| $600K | ﹤0.01% |
8,100
-255,200
| -97% | -$15.6M |
|
2703
Betterware México
BWMX
$613M
| $599K | ﹤0.01% |
43,000
-200
| -0.5% | -$2.92K |
|
2704
Phathom Pharmaceuticals
PHAT
$775M
| $599K | ﹤0.01% |
+65,600
| New | +$565K |
|
2705
Dimensional US Core Equity 2 ETF
DFAC
$49.9B
| $596K | ﹤0.01% |
20,400
-7,600
| -27% | -$206K |
|
2706
City Holding Co
CHCO
$2.07B
| $595K | ﹤0.01% |
5,400
-388
| -7% | -$38K |
|
2707
Hydrofarm Holdings
HYFM
$7M
| $595K | ﹤0.01% |
64,850
+1,960
| +3% | +$18.9K |
|
2708
Rimini Street
RMNI
$466M
| $595K | ﹤0.01% |
182,108
+82,686
| +83% | +$227K |
|
2709
Monte Rosa Therapeutics
GLUE
$1.32B
| $594K | ﹤0.01% |
105,200
+13,700
| +15% | +$53.7K |
|
2710
La-Z-Boy
LZB
$1.67B
| $594K | ﹤0.01% |
16,100
-7,000
| -30% | -$226K |
|
2711
Cerus
CERS
$601M
| $592K | ﹤0.01% |
274,100
-64,400
| -19% | -$106K |
|
2712
NatWest
NWG
$76B
| $591K | ﹤0.01% |
105,018
-261,382
| -71% | -$1.39M |
|
|
JCTC
2713
Jewett-Cameron Trading
JCTC
$10.2M
| $591K | ﹤0.01% |
108,828
-800
| -0.7% | -$3.89K |
|
|
JKS
2714
JinkoSolar
JKS
$877M
| $590K | ﹤0.01% |
15,962
-192,738
| -92% | -$6.22M |
|
2715
Comstock
LODE
$263M
| $588K | ﹤0.01% |
107,211
+49,601
| +86% | +$227K |
|
|
SSKN
2716
DELISTED
Strata Skin Sciences
SSKN
| $587K | ﹤0.01% |
106,745
-1,170
| -1% | -$6.08K |
|
2717
MainStreet Bancshares
MNSB
$177M
| $586K | ﹤0.01% |
23,600
+6,500
| +38% | +$139K |
|
2718
Legacy Housing
LEGH
$698M
| $585K | ﹤0.01% |
23,200
+11,500
| +98% | +$243K |
|
2719
LiveOne
LVO
$57.2M
| $585K | ﹤0.01% |
42,093
+3,973
| +10% | +$42.1K |
|
|
CTHR
2720
DELISTED
Charles & Colvard Ltd
CTHR
| $584K | ﹤0.01% |
142,357
+16,956
| +14% | +$70.3K |
|
2721
Solid Power
SLDP
$552M
| $581K | ﹤0.01% |
+400,900
| New | +$601K |
|
|
TRIB
2722
Trinity Biotech
TRIB
$7.88M
| $581K | ﹤0.01% |
9,026
-62
| -0.7% | -$4.44K |
|
|
ACR
2723
ACRES Commercial Realty
ACR
$102M
| $580K | ﹤0.01% |
+60,294
| New | +$491K |
|
2724
Comscore
SCOR
$93.6M
| $570K | ﹤0.01% |
34,136
+8,794
| +35% | +$113K |
|
2725
Aegon
AEG
$14B
| $569K | ﹤0.01% |
98,743
-333,753
| -77% | -$1.73M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.